Header Logo

Connection

Ian Dunn to Programmed Cell Death 1 Receptor

This is a "connection" page, showing publications Ian Dunn has written about Programmed Cell Death 1 Receptor.
Connection Strength

0.047
  1. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022 01 05; 24(1):101-113.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.